Hybridoma Development Studies and Antibody Production
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- HT942525R0009
- Agency
- Defense Health Agency Department of Defense
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Shelley Wallace shelley.a.wallace2.civ@health.mil (301) 619-3152
- Emily K. O'Hara emily.k.ohara.civ@health.mil (301) 619-9599
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency is seeking a small business contractor to conduct hybridoma development studies and antibody production for the Division of Virology at the USAMRIID. The solicitation involves severable, non-personal services focused on specialized research in molecular virology, cell biology, immunology, viral virulence factor determination, and viral strain diversity characterization. While specific evaluation criteria are not detailed in the notice, the contract appears to require advanced scientific capabilities in biological product development and research methodologies. The solicitation was posted on November 26, 2024, with proposals due by December 31, 2024, indicating a relatively short response window of approximately one month for interested contractors. The procurement is categorized under the Biological Product Manufacturing NAICS code (325414) and the Drugs and Biologicals PSC category (6505).
The contract is designated as a Total Small Business set-aside, which means only small business entities are eligible to compete for this opportunity. The place of performance is likely to be at the USAMRIID research facility, though specific location details are not provided in the notice. The solicitation does not specify potential award values, contract duration, or precise quantities of services required. The contract appears to be for scientific research services related to viral studies, suggesting a specialized and potentially complex scope of work. Prospective contractors should possess demonstrated expertise in biological research, cell culture techniques, antibody development, and virology-related scientific methodologies to be competitive for this federal contract opportunity.
Notice text
This is combined synopsis/solicitation for severable, non-personal service(s) contract to provide hybridoma development studies and antibody production for the Division of Virology at the USAMRIID, who conducts research in molecular virology, cell biology, immunology, viral virulence factor determination, and viral strain diversity characterization.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Hybridoma Development Studies and Antibody Production | Award Notice | |
| Hybridoma Development Studies and Antibody Production | Solicitation | |
| Hybridoma Development Studies | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity